
#485 — The New Science of Cancer
Making Sense with Sam Harris
00:00
Generics Will Lower Cancer Drug Costs After Patent Expiry
- Patent cycles reduce prices when drugs go generic, but companies often try to extend monopolies; respect patents yet insist generics replace high-cost drugs after protection ends.
- Mukherjee expects soon-to-be-generic immunotherapies to lower costs dramatically once generics enter the market.
Play episode from 55:40
Transcript


